What is the current Price Target for the NRX Pharmaceuticals Inc stock?

The average NRX Pharmaceuticals Inc target price is $37.74. This is 1,313.48% higher than the current stock price. The highest price target is 1,708.99%, the lowest is 845.69%. 6 Analysts have issued a price target NRX Pharmaceuticals Inc 2026 .

How high will the NRX Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the NRX Pharmaceuticals Inc stock will rise. The performance of stocks, including the NRX Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the NRX Pharmaceuticals Inc stock today?

The performance of NRX Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the NRX Pharmaceuticals Inc stock fall?

The decline in NRX Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

NRX Pharmaceuticals Inc Forecast, price target & analysts

$2.51

6.18% today

Nasdaq, Nov 07, 05:51 pm CET

ISIN

US6294441000

Symbol

NRXP

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

NRX Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

NRX Pharmaceuticals Inc Classifications & Recommendation:

Buy

90%

Hold

10%

NRX Pharmaceuticals Inc Price Target

Target Price	$37.74
Price	$2.67
Potential	1,313.48% register free of charge
Number of Estimates	6

	6 Analysts have issued a price target NRX Pharmaceuticals Inc 2026 . The average NRX Pharmaceuticals Inc target price is $37.74. This is 1,313.48% register free of charge higher than the current stock price. The highest price target is $48.30 1,708.99% register free of charge , the lowest is $25.25 845.69% register free of charge .
	A rating was issued by 10 analysts: 9 Analysts recommend NRX Pharmaceuticals Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the NRX Pharmaceuticals Inc stock has an average upside potential 2026 of 1,313.48% register free of charge . Most analysts recommend the NRX Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.36	-0.29
	490.00%	87.71%
P/E		negative
EV/Sales		2.66

6 Analysts have issued a NRX Pharmaceuticals Inc forecast for earnings per share. The average NRX Pharmaceuticals Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.36	490.00%
2025	$-0.29 87.71% Unlock
2026	$0.34 217.24% Unlock
2027	$2.58 658.82% Unlock
2028	$5.10 97.67% Unlock
2029	$5.60 9.80% Unlock
2030	$6.00 7.14% Unlock

Current	-1.42	89.71%
2025	-9.35 558.36% Unlock
2026	7.81 183.53% Unlock
2027	1.03 86.81% Unlock
2028	0.52 49.51% Unlock
2029	0.48 7.69% Unlock
2030	0.45 6.25% Unlock

NRX Pharmaceuticals Inc...

Current NRX Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Ascendiant Capital	Locked ➜ Locked	Locked	Oct 30 2025
D. Boral Capital	Locked ➜ Locked	Locked	Oct 21 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 16 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Oct 01 2025
D. Boral Capital	Locked ➜ Locked	Locked	Sep 29 2025
D. Boral Capital	Locked ➜ Locked	Locked	Sep 25 2025
D. Boral Capital	Locked ➜ Locked	Locked	Sep 08 2025

Analyst Rating	Date
Locked Ascendiant Capital: Locked ➜ Locked	Oct 30 2025
Locked D. Boral Capital: Locked ➜ Locked	Oct 21 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 16 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Oct 01 2025
Locked D. Boral Capital: Locked ➜ Locked	Sep 29 2025
Locked D. Boral Capital: Locked ➜ Locked	Sep 25 2025
Locked D. Boral Capital: Locked ➜ Locked	Sep 08 2025

Discover more stocks with a high price target

TUI 61.53%

Novo Nordisk 60.25%

Adidas 51.38%

Deutsche Telekom 47.10%

Meta Platforms (Facebook) 44.20%

Coinbase Global, Inc. 39.58%

BYD 38.89%

Adyen 36.70%

BioNTech SE - ADR 34.72%

Rheinmetall 31.38%

Microsoft 29.27%

Netflix 29.24%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now